The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Research Grant, 2020Alpha-synuclein Toxicity in LRRK2 Knock-in Models and Rescue by LRRK2 Silencing
Study Rationale:
Gene mutations that alter the function of the LRRK2 protein are known to increase the risk of developing Parkinson’s disease (PD). One of the pathological hallmarks of PD is the... -
Therapeutic Pipeline Program, 2020Novel Candidate against Alpha-synuclein for the Treatment of Parkinson’s Disease
Study Rationale:
The goal of this program is to develop a novel drug for Parkinson’s disease with a unique mechanism of action. We have a drug candidate that shows potential as an inhibitor of alpha... -
Therapeutic Pipeline Program, 2020Photoreceptor-Directed Light Therapy in Parkinson’s Disease
Study Rationale:
Non-motor symptoms including sleep disturbances are common and enormously impact quality of life in people with Parkinson’s disease (PD). Sleep disruption affects motor function... -
Research Grant Supplement, 2020Discovery of Selective PET Imaging Agents for Tauopathies and Alpha-Synuclein
Study Rationale:
The development of alpha-synuclein and tau imaging agents will be valuable for people with Parkinson’s disease and Frontal Temporal Dementia (FTD), as deposits of these proteins... -
Research Grant, 2020Parkinson’s Disease Subtyping by Genetic and Intestinal Inflammation Biomarkers
Study Rationale:
Parkinson’s disease (PD) is the second most common neurodegenerative disease worldwide. Currently, no drugs are available to treat or prevent the disease because the processes... -
Biosample Use Program, 2020Adaptive Immune Markers for Predicting Cognitive Decline in Parkinson’s Disease
Study Rationale:
For reasons not well understood, people with Parkinson's disease are at risk for developing dementia, a decline in memory, thinking and/or language abilities severe enough to...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.